Microbot Medical (MBOT) Shares Outstanding (Diluted Average) (2022 - 2026)

Microbot Medical has reported Shares Outstanding (Diluted Average) for 5 years, with the latest figure at $67.2 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding (Diluted Average) rose 116.04% year-over-year to $67.2 million; the trailing twelve-month figure through Mar 2026 stood at $67.2 million (up 116.04% YoY), and the FY2025 full-year result was $45.8 million, up 192.69% from the prior year.
• Shares Outstanding (Diluted Average) for Q1 2026 stood at $67.2 million, up from $45.8 million in the prior quarter.
• The five-year high for Shares Outstanding (Diluted Average) was $67.2 million in Q1 2026, with the low at $7.1 million in Q2 2022.
• Historically, Shares Outstanding (Diluted Average) has averaged $21.0 million across 5 years, with a median of $14.3 million in 2024.
• Annual changes were most pronounced in 2023 — Shares Outstanding (Diluted Average) gained 29.41% — and 2025, when it jumped 192.69%.
• Microbot Medical's Shares Outstanding (Diluted Average) stood at $7.3 million in 2022, then jumped by 40.49% to $10.2 million in 2023, then soared by 53.38% to $15.6 million in 2024, then surged by 192.69% to $45.8 million in 2025, then jumped by 46.66% to $67.2 million in 2026.
• The last three Shares Outstanding (Diluted Average) figures came in at $67.2 million (Q1 2026), $45.8 million (Q4 2025), and $38.6 million (Q3 2025), per Business Quant data.